Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.
about
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsIncreased eicosanoid levels in the Sugen/chronic hypoxia model of severe pulmonary hypertensionThe ω-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling.Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical TrialAMP activated protein kinase is indispensable for myocardial adaptation to caloric restriction in mice.Docosahexaenoic acid supplementation alters key properties of cardiac mitochondria and modestly attenuates development of left ventricular dysfunction in pressure overload-induced heart failureSerum concentration of eicosapentaenoic acid is associated with cognitive function in patients with coronary artery diseaseAssociation of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health studyDietary Omega-3 Polyunsaturated Fatty Acids Suppress NHE-1 Upregulation in a Rabbit Model of Volume- and Pressure-Overload.Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.How Are n-3 LCPUFAs Antiarrhythmic? A Reassessment of n-3 LCPUFAs in Cardiac Disease.EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4Sildenafil reduces signs of oxidative stress in pulmonary arterial hypertension: Evaluation by fatty acid composition, level of hydroxynonenal and heart rate variabilityMarine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure but do not improve survival.Red blood cell fatty acid levels improve GRACE score prediction of 2-yr mortality in patients with myocardial infarctionEvaluation of docosahexaenoic acid in a dog model of hypertension induced left ventricular hypertrophy.Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure.The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate.Fish oil selectively improves heart function in a mouse model of lipid-induced cardiomyopathyInverse relationship between long-chain n-3 fatty acids and risk of sudden cardiac death in patients starting hemodialysis.Regulation of thrombospondin-1 expression in alternatively activated macrophages and adipocytes: role of cellular cross talk and omega-3 fatty acidsOld dog, new tricks: novel cardiac targets and stress regulation by protein kinase G.ω-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP/TAZ degradation.Highly purified eicosapentaenoic acid ameliorates cardiac injury and adipose tissue inflammation in a rat model of metabolic syndrome.Benefits of omega-3 fatty acid against bone changes in salt-loaded rats: possible role of kidney.Two-wave nanotherapy to target the stroma and optimize gemcitabine delivery to a human pancreatic cancer model in miceDHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?The use of ω-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes.Fatty acids and cardiac disease: fuel carrying a message.Sudden cardiac death in haemodialysis patients: preventative options.Docosahexaenoic acid reverses angiotensin II-induced RECK suppression and cardiac fibroblast migration.Cardiac spheroids as promising in vitro models to study the human heart microenvironment.Protein kinase G signaling in cardiac pathophysiology: Impact of proteomics on clinical trials.ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.The relation of red blood cell fatty acids with vascular stiffness, cardiac structure and left ventricular function: the Framingham Heart Study.Galectin-3, a marker of cardiac remodeling, is inversely related to serum levels of marine omega-3 fatty acids. A cross-sectional study.18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling.n-3 Polyunsaturated Fatty Acids: Promising Nutrients for Preventing Cardiovascular Disease.
P2860
Q26745566-3613A406-B0AD-4F0E-AC17-65FB1039167BQ28544637-59285359-7021-4016-BBA5-68CC647B4566Q33567788-8ECE6429-1523-487B-A80F-74270C30ACB5Q34536010-1455F3AC-2041-4829-8798-89B9A2FB3806Q34635436-708F2D3D-622A-49E9-91A5-73582DE95461Q35191017-06E6BF6E-4CB7-4679-B46F-488059419891Q35341268-E9775A15-3958-4D16-891F-2329F80C024CQ35827241-52F43D0B-E9CF-4578-AA99-0F0B13B11AB4Q35865084-BFF12242-A78F-419E-9A71-EF6BA60C306EQ35974413-CF150B05-8EDC-4FE5-8088-9767B90FD5B2Q36199969-29E76C3F-B9CC-4A1F-897A-98790B4BDD0BQ36307290-5D7C0CB8-DCA5-499B-A264-1665497F2F59Q36382353-89E5E2AA-83AC-443A-A82C-68357FEECD50Q36528123-A56316F2-BD75-4F80-AF9A-6BD0F45869E1Q36616072-2E99B9C2-97E8-4B91-86E4-BC5BB3873D24Q36691953-C315A149-F51A-4518-8E5E-7F9E6F5E8F39Q36714191-1FB356F9-316A-4247-B2AE-18ADBAD54E9EQ36749450-72CB9128-06BD-40C4-B45B-0390DCE4784CQ36754545-D14EC53B-009D-4F7D-BF0A-DE0AC40DA133Q36847322-F4E60A8D-884A-46AE-BB56-9766D21E9C54Q36961554-804C7D45-6B26-47C7-A065-DD5745403348Q37075920-7D9EBA35-D74A-4CEE-BADC-049B9AF31D29Q37111117-76E154B4-FF19-4AA9-832D-E5A148E52D83Q37299065-166ADBC9-5DAA-4EDA-9B4A-FFD9595EE383Q37344144-3E68F34C-5FB6-4892-8ACF-6111D763AAB9Q37426354-07EE7369-6B28-407D-9F9A-D9C8DB700326Q37671776-9586CF60-CA9D-4B57-8D14-94DA37CABDFFQ37931014-D91A6312-4188-457D-AB91-8AC5EAAECC25Q38014342-24F3195C-1644-4A82-A40F-A664E3CE3C2CQ38207743-1E26E437-8851-4EB7-9CC3-111FDB519811Q38250885-A7498EB7-9B43-4A11-835A-D8146737C690Q38261562-2EFDB3CF-9156-4D6C-BD61-247CA539E0B5Q38647934-BF7FD79A-BF3F-4FDB-8F1F-4736D552B322Q38670275-2F9780A6-623D-4F03-A66B-581813B54BA9Q39041784-EEDE22AB-12DE-4799-A25E-57D8C6784A0BQ40985507-9A27838C-E46D-4635-BE9F-D3166BAD064AQ41675416-7C5FECEE-D031-4C86-A8B5-7089D4198FE5Q41716070-91A3C7CB-1E6C-4EBC-A718-F8E746D9DA53Q41810714-D9412AE9-1E3B-46ED-BEEF-1E78DA9E6FCFQ42629523-B10123C5-2E23-4252-9BA6-95C842A32E55
P2860
Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@ast
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@en
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@nl
type
label
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@ast
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@en
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@nl
prefLabel
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@ast
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@en
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@nl
P2093
P2860
P1433
P1476
Omega-3 fatty acids prevent pr ...... naling in cardiac fibroblasts.
@en
P2093
A Martin Gerdes
April J Beyer
Chastity L Healy
Dajun Wang
Gregory C Shearer
Jinghai Chen
Quanhai Chen
Timothy D O'Connell
Vijaya B Nareddy
William S Harris
P2860
P304
P356
10.1161/CIRCULATIONAHA.110.971853
P407
P577
2011-01-31T00:00:00Z